Corcept Therapeutics Inc Azioni (CORT) Dati Finanziari
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues | 32.92%340.47 | 256.15 | 164.90 | 202.13 | 207.64 |
| Cost Of Revenue | 13.47%4.61 | 4.06 | 2.88 | 2.55 | 4.60 |
4.80%164.43 | 156.90 | 145.36 | 130.24 | - | |
| Selling, General, and Administrative | 4.80%164.43 | 156.90 | 145.36 | 130.24 | - |
| Research and Development | 5.23%56.71 | 53.89 | 66.27 | 64.86 | - |
| Costs And Expenses | 5.07%225.75 | 214.85 | 214.50 | 197.64 | 197.42 |
| Operating Income/Loss | 177.78%114.72 | 41.30 | -49.60 | 4.49 | 10.22 |
| Nonoperating Income/Loss | 20.56%5.58 | 4.63 | 4.89 | 5.42 | 5.02 |
| Income/Loss From Continuing Operations Before Tax | 161.93%120.31 | 45.93 | -44.72 | 9.91 | 15.24 |
| Income Tax Expense/Benefit, Deferred | 233.60%9.61 | 2.88 | -13.11 | -15.18 | 9.11 |
| Income Tax Expense/Benefit | 319.80%-6.47 | 2.94 | -12.95 | -14.38 | -4.43 |
194.92%126.78 | 42.99 | -31.76 | 24.29 | 19.67 | |
| Attributable To Parent | 194.92%126.78 | 42.99 | -31.76 | 24.29 | 19.67 |
| Available To Common Stockholders, Basic | 195.41%124.49 | 42.14 | -31.20 | 23.90 | 19.36 |
| Basic Average Shares | 1.19%106.63 | 105.38 | 104.44 | - | 103.55 |
| Diluted Average Shares | 4.07%123.20 | 118.39 | 104.44 | - | 119.44 |
| Basic Earnings Per Share | 192.50%1.17 | 0.40 | -0.30 | - | 0.19 |
| Diluted Earnings Per Share | 180.56%1.01 | 0.36 | -0.30 | - | 0.16 |